260 related articles for article (PubMed ID: 28603070)
21. Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application.
Navarro-Bailón A; Carbonell D; Escudero A; Chicano M; Muñiz P; Suárez-González J; Bailén R; Oarbeascoa G; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32854376
[TBL] [Abstract][Full Text] [Related]
22. Chimerism-based pre-emptive immunotherapy with fast withdrawal of immunosuppression and donor lymphocyte infusions after allogeneic stem cell transplantation for pediatric hematologic malignancies.
Horn B; Petrovic A; Wahlstrom J; Dvorak CC; Kong D; Hwang J; Expose-Spencer J; Gates M; Cowan MJ
Biol Blood Marrow Transplant; 2015 Apr; 21(4):729-37. PubMed ID: 25644958
[TBL] [Abstract][Full Text] [Related]
23. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
24. Analysis of chimerism during the early period after allogeneic peripheral stem cell transplantation.
Gleissner B; Blau IW; Sindram A; Reinhardt R; Knauf W; Thiel E
Clin Lab Haematol; 2001 Dec; 23(6):401-6. PubMed ID: 11843889
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic peripheral blood stem cell transplantation and early detection of donor engraftment by polymerase chain reaction.
Tzeng CH; Lyou JY; Lin JS; Chen YR; Hu HY; Yung CH; Wang SY; Lee JC
J Formos Med Assoc; 1998 Apr; 97(4):252-60. PubMed ID: 9585676
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of chimerism in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation].
Furukawa T; Hashimoto S; Inano K; Yamazaki F; Takeda H; Kakihara T; Yano T; Abe T; Higuchi W; Toba K; Takahashi M; Koike T; Aizawa Y
Rinsho Ketsueki; 2001 Jun; 42(6):488-95. PubMed ID: 11505528
[TBL] [Abstract][Full Text] [Related]
27. Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms.
Valero-Garcia J; González-Espinosa MDC; Barrios M; Carmona-Antoñanzas G; García-Planells J; Ruiz-Lafora C; Fuentes-Gálvez A; Jiménez-Velasco A
PLoS One; 2019; 14(2):e0212708. PubMed ID: 30794643
[TBL] [Abstract][Full Text] [Related]
28. Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci.
Beck O; Seidl C; Lehrnbecher T; Kreyenberg H; Schwabe D; Klingebiel T; Seifried E; Bader P; Koehl U
Eur J Haematol; 2006 Mar; 76(3):237-44. PubMed ID: 16451397
[TBL] [Abstract][Full Text] [Related]
29. Real-time qPCR for chimerism assessment in allogeneic hematopoietic stem cell transplants from unrelated adult and double umbilical cord blood.
Frankfurt O; Zitzner JR; Tambur AR
Hum Immunol; 2015 Mar; 76(2-3):155-60. PubMed ID: 25636574
[TBL] [Abstract][Full Text] [Related]
30. Digital droplet PCR-based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation.
Mika T; Baraniskin A; Ladigan S; Wulf G; Dierks S; Haase D; Schork K; Turewicz M; Eisenacher M; Schmiegel W; Schroers R; Klein-Scory S
Int J Lab Hematol; 2019 Oct; 41(5):615-621. PubMed ID: 31225701
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation with amelogenin marker.
Ghaffari SH; Chahardouli B; Gavamzadeh A; Alimoghaddam K
Arch Iran Med; 2008 Jan; 11(1):35-41. PubMed ID: 18154421
[TBL] [Abstract][Full Text] [Related]
32. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
[TBL] [Abstract][Full Text] [Related]
33. Quantitative assessment of hematopoietic chimerism by quantitative real-time polymerase chain reaction of sequence polymorphism systems after hematopoietic stem cell transplantation.
Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
Chin Med J (Engl); 2011 Aug; 124(15):2301-8. PubMed ID: 22029079
[TBL] [Abstract][Full Text] [Related]
34. Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.
Jiang Y; Wan L; Qin Y; Wang X; Yan S; Xie K; Wang C
PLoS One; 2015; 10(7):e0133671. PubMed ID: 26226104
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene.
Wang LJ; Chou P; Gonzalez-Ryan L; Huang W; Haut PR; Kletzel M
Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144
[TBL] [Abstract][Full Text] [Related]
36. [The kinetics of hematopoietic cell chimerism in the early period after non-myeloablative transplantation and its clinical implications].
Xiao XB; Sun QY; Guo M; Qiao JH; Yu CL; Ai HS
Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):466-9. PubMed ID: 15555261
[TBL] [Abstract][Full Text] [Related]
37. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
[TBL] [Abstract][Full Text] [Related]
38. Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation: Comparison of Two Chimerism Test Strategies, Next-Generation Sequencing versus a Combination of Short-Tandem Repeats and Quantitative PCR.
Zhang A; Macecevic S; Thomas D; Allen J; Mandley S; Kawczak P; Jurcago R; Tyler J; Casey H; Bosler D; Sobecks R; Hamilton B; Sauter C; Mineishi S; Claxton D; Shike H
J Mol Diagn; 2024 Apr; 26(4):233-244. PubMed ID: 38307253
[TBL] [Abstract][Full Text] [Related]
39. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers.
Thiede C; Bornhäuser M; Oelschlägel U; Brendel C; Leo R; Daxberger H; Mohr B; Florek M; Kroschinsky F; Geissler G; Naumann R; Ritter M; Prange-Krex G; Lion T; Neubauer A; Ehninger G
Leukemia; 2001 Feb; 15(2):293-302. PubMed ID: 11236950
[TBL] [Abstract][Full Text] [Related]
40. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
